WPL06910 - Peritoneal Malignancy Outsourcing - Elective CRS and HIPEC

HAMPSHIRE HOSPITALS NHS FOUNDATION TRUST

Value
Not stated
Published
17 Sept 2026
Deadline
Not stated
Procedure
Not stated
Category
85111000 — Hospital services
Location
UKI
Notice reference
088141-2026

Requirements summary

Hampshire Hospitals NHS Foundation Trust is planning to procure a qualified sub-contractor to provide specialised Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) capacity for patients with Pseudomyxoma Peritonei and Colorectal Peritoneal Metastases. The service is a consultant-led, integrated tertiary care sub-contract covering the full pathway from pre-operative assessment to discharge. The notice is a planned intended-approach notice under the Provider Selection Regime, with expressions of interest due by 23:59 on 1 October 2026.

Key requirements

  • Qualified sub-contractor providing CRS and HIPEC surgical capacity
  • Care for patients with Pseudomyxoma Peritonei (PMP) and Colorectal Peritoneal Metastases (CPM)
  • Consultant-led, fully integrated tertiary care with end-to-end pathway delivery
  • Pathway to include pre-operative assessment, surgery, Level 2/3 critical care, inpatient ward care and discharge management
  • Lot 1: site accessibility via major transport hubs, with London support networks, for regions UKI and UKJ
  • Lot 2: dedicated on-site or partnered accommodation for patient relatives in UKJ, including out-of-region patients
WPL06910 - Peritoneal Malignancy Outsourcing - Elective… | ProposAI